Sanofi says authorities to assess new flu vaccine

PARIS Thu Apr 11, 2013 1:21am EDT

Chris Viehbacher, Chief Executive Officer of Sanofi, attends the company's 2012 annual results presentation in Paris February 7, 2013. REUTERS/Jacky Naegelen

Chris Viehbacher, Chief Executive Officer of Sanofi, attends the company's 2012 annual results presentation in Paris February 7, 2013.

Credit: Reuters/Jacky Naegelen

Related Topics

PARIS (Reuters) - Sanofi said European authorities have agreed to review a marketing application for a new flu vaccine designed to combat the four strains of virus expected in the coming season.

The company's Sanofi Pasteur vaccine unit currently produces the three-strain Vaxigrip flu vaccine at a facility in Val de Rueil, in France.

The marketing authorization application for the quadrivalent version of Vaxigrip is intended to be presented in all countries of the world where Vaxigrip is currently commercialized, Sanofi said in a statement on Thursday.

(Reporting by James Regan; Editing by Blaise Robinson)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Pictures